Olmo Sonzogni
- Oncology top 10%
- Molecular Biology
- Immunology top 10%
- Pulmonary and Respiratory Medicine
- Plant Science
- Co-authors
- Stephanie SteidlerD. TedescoS. GallettiLicia RavarottoGerburg M. WulfJocelin PintoJessica A. CastrillonSven Rottenberg
- Topics
- Antibiotics Pharmacokinetics and Efficacy (10 papers)Antibiotic Resistance in Bacteria (4 papers)Veterinary Pharmacology and Anesthesia (4 papers)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Olmo Sonzogni
17 papers receiving 720 citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 361
- Molecular Biology 281
- Immunology 262
- Pulmonary and Respiratory Medicine 144
- Plant Science 102
Countries citing papers authored by Olmo Sonzogni
This map shows the geographic impact of Olmo Sonzogni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olmo Sonzogni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olmo Sonzogni more than expected).
Fields of papers citing papers by Olmo Sonzogni
This network shows the impact of papers produced by Olmo Sonzogni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olmo Sonzogni. The network helps show where Olmo Sonzogni may publish in the future.
Co-authorship network of co-authors of Olmo Sonzogni
This figure shows the co-authorship network connecting the top 25 collaborators of Olmo Sonzogni. A scholar is included among the top collaborators of Olmo Sonzogni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olmo Sonzogni. Olmo Sonzogni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancerbreakdown → | 476 |
| 5 | 16 | |
| 6 | 0 | |
| 7 | 2 | |
| 8 | 185 | |
| 9 | 8 | |
| 10 | Residue depletion of oxytetracycline and doxycycline in the rabbit | 1 |
| 11 | 5 | |
| 12 | 9 | |
| 13 | 4 | |
| 14 | 11 | |
| 15 | 15 | |
| 16 | 5 | |
| 17 | 3 | |
| 18 | 4 |
About Olmo Sonzogni
Olmo Sonzogni is a scholar working on Small Animals, Molecular Medicine and Pharmacology, having authored 18 papers that have together received 760 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (4 papers) and Veterinary Pharmacology and Anesthesia (4 papers). The work is most often cited by research in Oncology (361 citations), Immunology (262 citations) and Animal Science and Zoology (49 citations). Olmo Sonzogni has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Stephanie Steidler, D. Tedesco, S. Galletti, Licia Ravarotto, Gerburg M. Wulf, Jocelin Pinto, Jessica A. Castrillon, Sven Rottenberg, Jos Jonkers and Constantia Pantelidou. Their work appears in journals such as Cancer Research, PLoS Biology and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.